Kommentar 1 zu CLTI: Bypassoperation oder endovaskuläre Therapie besser geeignet?

• Literatur

• 1 Farber A, Menard MT, Conte MS. et al. Surgery or endovascular therapy for chronic limb-threatening ischemia. New England Journal of Medicine 2022;
• 2 Aboyans V, Ricco JB, Bartelink ML. et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Kardiologia Polska (Polish Heart Journal) 2017; 75 (11) 1065-1160
• 3 Debus ES, Nehler MR, Govsyeyev N. et al. Effect of rivaroxaban and aspirin in patients with peripheral artery dis-ease undergoing surgical revascularization: insights from the VOYAGER PAD tri-al. Circulation 2021; 144 (14) 1104-1116
• 4 Dayama A, Tsilimparis N, Kolakowski S. et al. Clinical outcomes of by-pass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease. J Vasc Surg 2019; 69 (01) 156-163.e1